Tackling the increasing complexity of therapeutic monoclonal antibodies with mass spectrometry
Authors:
- Sara RosatiSRSara Rosati
- Natalie J. ThompsonNTNatalie J. Thompson
- Albert J.R. HeckAHAlbert J.R. Heck
- 1 July 2013
- journal article
- Published by Elsevier in TrAC Trends in Analytical Chemistry
- Vol. 48, 72-80
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Low Level Sequence Variant Analysis of Recombinant Proteins: An Optimized ApproachPLOS ONE, 2012
- Marketed therapeutic antibodies compendiummAbs, 2012
- Unit Mass Baseline Resolution for an Intact 148 kDa Therapeutic Monoclonal Antibody by Fourier Transform Ion Cyclotron Resonance Mass SpectrometryAnalytical Chemistry, 2011
- Quantitative Analysis of the Interaction Strength and Dynamics of Human IgG4 Half Molecules by Native Mass SpectrometryStructure, 2011
- Characterization and Comparison of Disulfide Linkages and Scrambling Patterns in Therapeutic Monoclonal Antibodies: Using LC-MS with Electron Transfer DissociationAnalytical Chemistry, 2011
- Norwalk Virus Assembly and Stability Monitored by Mass SpectrometryMolecular & Cellular Proteomics, 2010
- Implications of the presence of N-glycolylneuraminic acid in recombinant therapeutic glycoproteinsNature Biotechnology, 2010
- Enhancing Antibody Fc Heterodimer Formation through Electrostatic Steering EffectsJournal of Biological Chemistry, 2010
- High-resolution mass spectrometry of viral assemblies: Molecular composition and stability of dimorphic hepatitis B virus capsidsProceedings of the National Academy of Sciences, 2008
- Determination of primary structure and microheterogeneity of a β-amyloid plaque-specific antibody using high-performance LC–tandem mass spectrometryAnalytical and Bioanalytical Chemistry, 2008